357 related articles for article (PubMed ID: 28205331)
21. Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis.
Semb AG; Ikdahl E; Wibetoe G; Crowson C; Rollefstad S
Nat Rev Rheumatol; 2020 Jul; 16(7):361-379. PubMed ID: 32494054
[TBL] [Abstract][Full Text] [Related]
22. Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation.
Chen J; Norling LV; Cooper D
Cells; 2021 Apr; 10(4):. PubMed ID: 33924323
[TBL] [Abstract][Full Text] [Related]
23. Risk factors and early detection of atherosclerosis in rheumatoid arthritis.
de Groot L; Posthumus MD; Kallenberg CG; Bijl M
Eur J Clin Invest; 2010 Sep; 40(9):835-42. PubMed ID: 20597966
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular disease in patients with rheumatoid arthritis.
Liao KP
Trends Cardiovasc Med; 2017 Feb; 27(2):136-140. PubMed ID: 27612551
[TBL] [Abstract][Full Text] [Related]
25. Critical determinants of cardiovascular risk in rheumatoid arthritis.
Bisoendial RJ; Stroes ES; Tak PP
Curr Pharm Des; 2011; 17(1):21-6. PubMed ID: 21226666
[TBL] [Abstract][Full Text] [Related]
26. What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.
Dixon WG; Symmons DP
Ann Rheum Dis; 2007 Sep; 66(9):1132-6. PubMed ID: 17251223
[TBL] [Abstract][Full Text] [Related]
27. Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors.
Arida A; Zampeli E; Konstantonis G; Fragiadaki K; Kitas GD; Protogerou AD; Sfikakis PP
Clin Rheumatol; 2015 May; 34(5):853-9. PubMed ID: 25754335
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular co-morbidity in early rheumatoid arthritis.
John H; Kitas G; Toms T; Goodson N
Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):71-82. PubMed ID: 19233047
[TBL] [Abstract][Full Text] [Related]
29. Vascular calcification in rheumatoid arthritis: prevalence, pathophysiological aspects and potential targets.
Paccou J; Brazier M; Mentaverri R; Kamel S; Fardellone P; Massy ZA
Atherosclerosis; 2012 Oct; 224(2):283-90. PubMed ID: 22703866
[TBL] [Abstract][Full Text] [Related]
30. One year in review 2016: pathogenesis of rheumatoid arthritis.
Bellucci E; Terenzi R; La Paglia GM; Gentileschi S; Tripoli A; Tani C; Alunno A
Clin Exp Rheumatol; 2016; 34(5):793-801. PubMed ID: 27716458
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach.
Jurcuţ C; Jurcuţ R; Tănăsescu C
Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138
[TBL] [Abstract][Full Text] [Related]
32. How early is the atherosclerotic risk in rheumatoid arthritis?
Bartoloni E; Alunno A; Bistoni O; Gerli R
Autoimmun Rev; 2010 Aug; 9(10):701-7. PubMed ID: 20542146
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs.
Avouac J; Allanore Y
Expert Opin Pharmacother; 2008 May; 9(7):1121-8. PubMed ID: 18422470
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
Li C; Wang XR; Ji HJ; Zhang XY; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Wang GC; Lu X; Zhu P; Chen LN; Jin HT; Liu JT; Liu XY; Sun L; Chen HY; Wei P; Wang JX; Cui LF; Shu R; Liu BL; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Han SL; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Yang XY; Li H; Huang CB; Gao M; Lai B; Li XF; Song LJ; Wang Y; Wang XY; Tang YD; Su Y; Mu R; Li ZG
Clin Rheumatol; 2017 May; 36(5):1023-1029. PubMed ID: 28342151
[TBL] [Abstract][Full Text] [Related]
35. Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents.
Carbone F; Bonaventura A; Liberale L; Paolino S; Torre F; Dallegri F; Montecucco F; Cutolo M
Clin Rev Allergy Immunol; 2020 Feb; 58(1):1-14. PubMed ID: 30259381
[TBL] [Abstract][Full Text] [Related]
36. Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases.
Mackey RH; Kuller LH; Moreland LW
Rheum Dis Clin North Am; 2018 Aug; 44(3):475-487. PubMed ID: 30001787
[TBL] [Abstract][Full Text] [Related]
37. No increased cardiovascular mortality among early rheumatoid arthritis patients: a nationwide register study in 2000-2008.
Kerola AM; Nieminen TV; Virta LJ; Kautiainen H; Kerola T; Pohjolainen T; Kauppi MJ; Puolakka K
Clin Exp Rheumatol; 2015; 33(3):391-8. PubMed ID: 25936374
[TBL] [Abstract][Full Text] [Related]
38. Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link.
Bartoloni E; Alunno A; Luccioli F; Moscatelli S; Biscontini D; Santoboni G; Gerli R
Expert Rev Cardiovasc Ther; 2010 Sep; 8(9):1309-16. PubMed ID: 20828353
[TBL] [Abstract][Full Text] [Related]
39. Prevention of cardiovascular disease in rheumatoid arthritis.
Hollan I; Dessein PH; Ronda N; Wasko MC; Svenungsson E; Agewall S; Cohen-Tervaert JW; Maki-Petaja K; Grundtvig M; Karpouzas GA; Meroni PL
Autoimmun Rev; 2015 Oct; 14(10):952-69. PubMed ID: 26117596
[TBL] [Abstract][Full Text] [Related]
40. Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis.
Shen J; Shang Q; Tam LS
Transl Res; 2016 Jan; 167(1):138-51. PubMed ID: 26051628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
